This insight helps PlexusDx clinicians adjust your starting dose, escalation pace, and target dose to match your biology rather than generic protocols
To prevent therapeutic gaps, some clinicians recommend patients carry a backup pen when traveling, particularly for trips longer than one week or to remote destinations where pharmacy access may be limited
Increasing Awareness of GLP-1 Therapies Awareness of GLP-1 receptor agonists as effective treatment options for diabetes is steadily increasing in India
, ,
Patient has BMI between 27 and 30 but the documented comorbidity does not meet the plan's definition of obesity-related
Its a huge opportunity, says Kai Eberhardt, the founder and CEO of Oviva, a Swiss weight loss management platform which operates in the UK, France and Germany, alongside its home market